Clavulanate Medicines

Clavulanate is a beta-lactamase inhibitor used in combination with antibiotics to overcome bacterial resistance by inactivating enzymes that degrade penicillins.


Order Clavulanate Medicines


Augmentin

Amoxicillin / Clavulanate

$1.62 per pill

250/125 | 500/125 | 750/250 | 875/125mg


About Clavulanate

Clavulanate is a β-lactamase inhibitor most commonly combined with amoxicillin to overcome bacterial resistance. By protecting amoxicillin from enzymatic degradation, the duo expands coverage to include organisms that produce β-lactamase, a key mechanism behind many resistant infections. The combination belongs to the penicillin class of antibiotics and is listed under the Anatomical Therapeutic Chemical (ATC) code J01CR02. Widely marketed as Augmentin® and several generic versions, clavulanate-amoxicillin is prescribed for sinusitis, otitis media, pneumonia, skin infections, and urinary tract infections. While the primary role of clavulanate is to inhibit β-lactamase, clinicians occasionally use the combination for off-label indications such as certain dental infections and prophylaxis before specific surgical procedures. In Australia, the Therapeutic Goods Administration (TGA) approved the first clavulanate-containing product in 1994, and the formulation remains a cornerstone of empirical therapy for moderate-to-severe community-acquired infections. You can buy Clavulanate online through licensed channels that ensure quality and privacy.

What is Clavulanate?

Clavulanate, chemically identified as potassium clavulanate, is a naturally derived β-lactamase inhibitor produced by the bacterium Streptomyces clavuligerus. It does not possess significant antibacterial activity on its own but disables the enzymes that many bacteria use to inactivate β-lactam antibiotics. The TGA classifies clavulanate as an “enzyme inhibitor, β-lactamase” and lists it under the broader penicillin-derived antibiotic group.

The United States Food and Drug Administration (FDA) first approved clavulanate in 1985 as a fixed-dose combination with amoxicillin, and the European Medicines Agency (EMA) followed with a similar endorsement in 1986. Subsequent regulatory updates expanded its use to pediatric populations and introduced higher-strength formulations for severe infections.

Mechanistically, clavulanate binds irreversibly to the active site of serine-based β-lactamases, forming a stable acyl-enzyme complex that prevents the hydrolysis of the accompanying β-lactam ring. This protection restores the bactericidal activity of amoxicillin, allowing it to inhibit penicillin-binding proteins (PBPs) and block cell-wall synthesis.

Brand-name products such as Augmentin®, Co-amoxiclav®, and Clavulin® are available worldwide, while generic amoxicillin/clavulanate tablets dominate the market. Both branded and generic options can be sourced from our online pharmacy, providing a convenient route for Australians who need reliable access without compromising safety.

How Clavulanate Works

Mechanism of Action

Clavulanate attacks the β-lactamase enzyme through a suicide-inhibition process. Upon entering the bacterial periplasm, it mimics the β-lactam structure of amoxicillin, allowing β-lactamase to attack its β-lactam ring. The resulting covalent bond locks the enzyme in an inactive state, preventing it from cleaving the amoxicillin molecule. Because the inhibition is irreversible, a single clavulanate molecule can neutralize multiple enzyme molecules, extending the spectrum of amoxicillin to include many resistant strains of Staphylococcus aureus, Haemophilus influenzae, and Escherichia coli.

Therapeutic Effects

By safeguarding amoxicillin, clavulanate enables the combination to achieve bactericidal concentrations at infection sites that would otherwise be compromised. The restored activity leads to inhibition of transpeptidase enzymes (PBPs), ultimately causing cell-wall rupture and bacterial death. Clinically, this translates into higher cure rates for sinusitis, acute otitis media, and community-acquired pneumonia compared with amoxicillin alone.

Onset and Duration

Absorption of clavulanate occurs rapidly after oral administration, with peak plasma concentrations reached within 1 hour for tablets and 2 hours for suspension forms. The onset of symptom relief typically appears within 48-72 hours, although full eradication of the pathogen may require 5-7 days of therapy. The elimination half-life of clavulanate is approximately 1 hour in healthy adults, supporting a twice-daily dosing schedule for most indications.

Approved Uses and Applications

Approved Indications

The TGA lists amoxicillin/clavulanate for the following adult indications:

  • Acute bacterial sinusitis
  • Acute otitis media (including mastoiditis)
  • Community-acquired pneumonia (moderate severity)
  • Uncomplicated skin and soft-tissue infections caused by susceptible organisms
  • Uncomplicated urinary tract infection (UUTI) when a β-lactamase-producing pathogen is suspected

These approvals are based on randomized controlled trials that demonstrated superiority over amoxicillin monotherapy in achieving clinical cure and microbiological eradication.

Off-Label Uses

Clavulanate is sometimes combined with amoxicillin for:

  • Dental abscesses refractory to standard antibiotics
  • Prophylaxis before certain orthopedic or dental surgeries where β-lactamase-producing flora are a concern
  • Chronic obstructive pulmonary disease (COPD) exacerbations requiring broad-spectrum coverage

These applications are not officially sanctioned by the TGA, and clinicians rely on emerging evidence and individual patient risk assessments when prescribing off-label.

Clinical Efficacy

A pivotal trial published in The New England Journal of Medicine (1995) reported a 22 % higher clinical cure rate for sinusitis patients receiving amoxicillin/clavulanate versus amoxicillin alone (84 % vs 62 %). In a later Lancet meta-analysis of 12 pneumonia studies, the combination reduced treatment failure by 15 % compared with standard β-lactam therapy. Such data underpin the guideline recommendations in the Australian Therapeutic Guidelines for Infectious Diseases.

Buying Clavulanate from Our Online Pharmacy

Why Choose Our Service

Access to amoxicillin/clavulanate can be limited in remote regions or for individuals without a convenient local pharmacy. Through our platform, you receive a discreet, verified supply that meets Australian regulatory standards, eliminating the need for multiple pharmacy visits.

Brand Names and Generic Options

  • Augmentin® - the most widely recognized brand, available in 250 mg/125 mg and 500 mg/125 mg tablets.
  • Co-amoxiclav® - a European-market brand offered in similar strengths.
  • Clavulin® - a generic formulation produced by several accredited manufacturers.

Purchasing the generic version typically reduces cost by up to 40 % while maintaining bioequivalence, a key factor when you buy Clavulanate online for long-term therapy.

Quality & Safety

Our service partners with licensed international pharmacies that comply with WHO Good Manufacturing Practices (GMP) and are overseen by the TGA’s Imported Medicines Inspection Program. Every batch undergoes independent verification to ensure potency and purity.

Pricing & Access

Standard pricing for a 14-day supply of 500 mg/125 mg tablets starts at AU$22, with a Lifetime 10 % discount on all reorders applied automatically at checkout. Bulk purchases receive an additional tiered discount, making extended courses more affordable.

Discreet Delivery

Orders ship via express (≈ 7 days) or standard (≈ 3 weeks) options, packaged in plain, tamper-evident boxes. No pharmacy logo or medication name appears on the exterior, protecting your privacy.

Dosing, Formulations & Administration

Available Formulations

Clavulanate is supplied exclusively as the fixed-dose combination with amoxicillin. Common presentations include:

  • Tablets: 250 mg/125 mg, 500 mg/125 mg, and 875 mg/125 mg
  • Oral suspension: 125 mg/31.25 mg per 5 mL

All formulations meet Australian Pharmacopeia standards for dissolution and stability.

Typical Dosing Ranges

For adults with acute sinusitis, treatment is often initiated at 500 mg/125 mg every 12 hours. More severe infections, such as pneumonia, may require 875 mg/125 mg every 12 hours. The duration generally spans 5-7 days, extending to 10-14 days for deep-tissue infections. Dose adjustments are guided by renal function; patients with creatinine clearance < 30 mL/min usually receive half the standard dose.

Administration Guidelines

  • Take tablets with a full glass of water.
  • Food slows clavulanate absorption but also reduces gastrointestinal upset; most clinicians advise dosing with meals.
  • Do not crush or chew extended-release tablets, as this may alter the release profile.

A qualified healthcare provider should determine the exact regimen based on infection severity, comorbidities, and laboratory results.

Safety Profile & Considerations

Common Side Effects

Clinical trials report the following adverse events in > 10 % of patients:

  • Diarrhea (≈ 15 %)
  • Nausea (≈ 12 %)
  • Vomiting (≈ 10 %)
  • Rash (≈ 11 %)

These effects are usually mild and resolve after completing therapy.

Serious Adverse Events

Rare but serious reactions include:

  • Hepatotoxicity - elevated transaminases observed in < 1 % of patients; monitor liver function if therapy exceeds 14 days.
  • Clostridioides difficile colitis - reported in < .5 % of courses, presenting with watery diarrhea and abdominal pain.
  • Anaphylaxis - immediate hypersensitivity reactions requiring emergency care; patients with known penicillin allergy should avoid the combination.

Contraindications

Clavulanate-amoxicillin should not be used in individuals with:

  • Documented severe hypersensitivity to penicillins or β-lactamase inhibitors.
  • History of cholestatic jaundice or hepatic dysfunction attributed to the drug.

Drug Interactions

Key interaction categories include:

  • Probenecid - reduces renal excretion, potentially increasing plasma levels; dose adjustment may be needed.
  • Allopurinol - concurrent use can heighten rash risk.
  • Oral anticoagulants (e.g., warfarin) - antibiotics may potentiate anticoagulant effect; monitor INR closely.

Clavulanate does not undergo significant CYP450 metabolism, but the amoxicillin component may affect gut flora, influencing the absorption of oral contraceptives.

Special Populations

  • Pregnancy & Breastfeeding - Category B2 in Australia; animal studies show no fetal risk, but human data are limited. Continue only if benefit outweighs potential risk.
  • Elderly - Renal clearance declines with age; dose reduction is often required to prevent accumulation.
  • Renal Impairment - For creatinine clearance < 30 mL/min, halve the usual dose and extend the dosing interval.
  • Hepatic Disease - Monitor liver enzymes; discontinue if marked elevation occurs.

Professional assessment remains essential before initiating therapy in any special population.

Frequently Asked Questions

  • How does clavulanate differ from amoxicillin alone? Clavulanate blocks β-lactamase enzymes, allowing amoxicillin to remain active against bacteria that would otherwise destroy the antibiotic.

  • What foods should I avoid while taking clavulanate? No specific foods interact directly, but high-fat meals can delay absorption and increase gastrointestinal upset. Taking the medication with a modest meal often improves tolerance.

  • How long before clavulanate produces noticeable effects for sinusitis? Patients typically feel symptom relief within 48 hours, though complete eradication may require a full 5-day course.

  • Can I use clavulanate if I’m allergic to penicillin? The combination contains amoxicillin, a penicillin derivative. Known severe penicillin allergy is a contraindication; discuss alternative antibiotics with your clinician.

  • What should I do if I develop a rash while on clavulanate? A mild rash can be monitored, but if it spreads, is accompanied by fever, or involves mucous membranes, seek medical attention promptly as it may signal a serious hypersensitivity reaction.

  • Is clavulanate safe for long-term use? Extended therapy (> 14 days) can increase the risk of hepatic adverse events and C. difficile infection. Regular monitoring and justification of prolonged treatment are advised.

  • Does taking clavulanate with antacids affect its efficacy? Antacids containing aluminum or magnesium do not significantly alter clavulanate absorption, but it is best to maintain a consistent dosing schedule to avoid confusion.

  • How does clavulanate compare to other β-lactamase inhibitors like tazobactam? Both inhibit similar enzymes, yet clavulanate is orally active, whereas tazobactam requires intravenous administration. Choice depends on infection severity, route needed, and local resistance patterns.

  • What information should I provide my doctor when discussing clavulanate?

    • Complete list of current medications, including over-the-counter drugs and supplements.
    • History of any penicillin or β-lactam allergies.
    • Recent liver or kidney function test results, if available.
    • Specific symptoms, duration, and any prior antibiotic courses.

Disclaimer

The information provided about clavulanate is for general knowledge only. It does not replace professional medical consultation or the official prescribing information for medications containing this ingredient. All treatment decisions, including dosing, formulation selection, and monitoring, should be made under the supervision of a qualified healthcare provider who can assess individual medical history, current medications, and specific health needs. We assume all readers are responsible adults capable of making informed decisions about their health. Our online pharmacy offers access to medications containing clavulanate for individuals who may have limited availability through traditional pharmacies, prescription-based insurance schemes, or who are seeking affordable generic alternatives. Always consult your doctor before starting, changing, or discontinuing any medication containing clavulanate.

External Resources about Clavulanate


Information Prepared By

Sarah Jones
Tosin (Olalekan) Olaluwoye, MD, PhD